Sort
130,381 grants matching “hiv”
PS10-1001, HIV PREVENTION PROJECTS
$1,653,610Robert Lachance · Nh State Dept/Hlth Statistics/Data Mgmt · U62 · FY2010 · PS
The Southeastern Consortium for Microscopy of MacroMolecular Machines
$1,653,522Kenneth A Taylor · Florida State University · U24 · FY2017 · GM
Viral Vector Core
$1,653,435Negin Martin · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES
IeDEA West -Africa collaboration
$1,653,274Francois Dabis · Adera · U01 · FY2011 · AI
SPECIFIC PATHOGEN FREE RHESUS MACAQUE BREEDING PROGRAM
$1,652,724Alpha Genesis, Inc. · U01 · FY2002 · AI
Genetic Analysis of T-cell Differentiation
$1,652,581Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,652,477Luis J. Montaner · Wistar Institute · R01 · FY2022 · DA
Centers for AIDS Research (CFAR)
$1,652,403Kent J. Weinhold · Duke University · P30 · FY2015 · AI
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$1,652,306Walther H Mothes · University Of Utah · U54 · FY2023 · AI
Structure-Based CD-4-gp120 Antagonism
$1,652,278Drexel University · P01 · FY2005 · GM
National Neurological AIDS Bank (NNAB)
$1,652,260University Of California Los Angeles · R24 · FY2004 · NS
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,652,241Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Host Genetics Core
$1,651,833Norman L Letvin · Duke University · U19 · FY2010 · AI
Molecular Analysis of Tuberculosis Immunity
$1,651,620William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2013 · AI
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
$1,651,550Timothy J Wilkin · Weill Medical Coll Of Cornell Univ · U54 · FY2021 · CA
The origin, predictors, and immune correlates of viral rebound in orally SHIV infected infant monkeys
$1,651,483Sallie R. Permar · Duke University · P01 · FY2018 · AI
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
$1,651,405Zhi-Ming Zheng · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Structure-Based CD-4-gp120 Antagonism
$1,651,282Irwin M Chaiken · Drexel University · P01 · FY2006 · GM
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation
$1,651,121Christine Marie Durand · Johns Hopkins University · U01 · FY2021 · AI
Molecular Regulation Of RNA Metabolism
$1,650,971Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Alabama Clinical Trials Unit
$1,650,759Michael S. Saag · University Of Alabama At Birmingham · UM1 · FY2016 · AI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES
$1,650,681Barbara Driver · Westat, Inc. · N01 · FY2020 · HD
Immunological Strategies to Modulate SIV Rebound Following ART Interruption
$1,650,523Michael R Betts · University Of Pennsylvania · P01 · FY2017 · AI
Clinical Trials of Patients with AIDS-Related Malignancies
$1,650,515Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,650,506Public Health Foundation Enterprises · U01 · FY2005 · AI